Higher Uveitis Risk in Cancer Patients on BRAF Inhibitors

BRAF inhibitors raise the risk for uveitis in patients with skin melanoma or lung cancer compared with conventional cytotoxic drugs or immune checkpoint inhibitors.
Medscape Medical News

source https://www.medscape.com/viewarticle/higher-uveitis-risk-patients-cancer-braf-inhibitors-2024a1000ekr?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors